Eric Laub | Investor Relations |
Richard Murray | Chief Executive Officer and President |
Beth Trehu | Chief Medical Officer |
Dmitri Wiederschain | Chief Scientific Officer |
Kim Drapkin | Chief Financial Officer |
Ted Tenthoff | Piper Sandler |
Boris Peaker | Cowen |
Steven Seedhouse | Raymond James |
Colleen Kusy | Baird |
Zegbeh Jallah | Roth Capital Partners |
Swayampakula Ramakanth | H.C. Wainwright |
00:03 Good morning, ladies and gentlemen, and welcome to Jounce Therapeutics Third Quarter twenty twenty one Earnings Conference Call. At this time, all participant lines are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder this conference is being recorded at the company’s request. 00:24 I will now turn the call over to your host, Eric Laub with Jounce Therapeutics.